174 related articles for article (PubMed ID: 17224277)
1. Interleukin-1 receptor antagonist gene polymorphism affects the progression of chronic renal failure.
Buraczynska M; Ksiazek P; Kubit P; Zaluska W
Cytokine; 2006 Nov; 36(3-4):167-72. PubMed ID: 17224277
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-1beta and interleukin-1 receptor antagonist gene polymorphisms in Korean patients with adult-onset Still's disease.
Youm JY; Woo JH; Kim TH; Bae SC; Yoo DH
Scand J Rheumatol; 2007; 36(5):390-3. PubMed ID: 17963170
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-6 gene polymorphism and faster progression to end-stage renal failure in chronic glomerulonephritis.
Buraczynska M; Jozwiak L; Ksiazek P; Borowicz E; Mierzicki P
Transl Res; 2007 Aug; 150(2):101-5. PubMed ID: 17656329
[TBL] [Abstract][Full Text] [Related]
4. Genetic polymorphisms of the renin-angiotensin system in end-stage renal disease.
Buraczynska M; Ksiazek P; Drop A; Zaluska W; Spasiewicz D; Ksiazek A
Nephrol Dial Transplant; 2006 Apr; 21(4):979-83. PubMed ID: 16384824
[TBL] [Abstract][Full Text] [Related]
5. Interleukin 1 receptor antagonist and tumor necrosis factor-alpha gene polymorphism in patients with end-stage renal failure.
Shu KH; Cheng CH; Wu MJ; Chen CH; Lee WC
Ren Fail; 2005; 27(1):53-7. PubMed ID: 15717635
[TBL] [Abstract][Full Text] [Related]
6. Role of non-HLA genetic variants in end-stage renal disease.
Ranganath P; Tripathi G; Sharma RK; Sankhwar SN; Agrawal S
Tissue Antigens; 2009 Aug; 74(2):147-55. PubMed ID: 19497039
[TBL] [Abstract][Full Text] [Related]
7. Impact of interferon-gamma and interleukin-4 gene polymorphisms on development and progression of IgA nephropathy in Japanese patients.
Masutani K; Miyake K; Nakashima H; Hirano T; Kubo M; Hirakawa M; Tsuruya K; Fukuda K; Kanai H; Otsuka T; Hirakata H; Iida M
Am J Kidney Dis; 2003 Feb; 41(2):371-9. PubMed ID: 12552499
[TBL] [Abstract][Full Text] [Related]
8. [Study on the polymorphism of interleukin-1 gene and the susceptibility to essential hypertension].
Li Y; Xu P; Zhang PA; Li XY; Huang CX
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Oct; 21(5):491-3. PubMed ID: 15476179
[TBL] [Abstract][Full Text] [Related]
9. Genotypic and functional roles of IL-1B and IL-1RN on the risk of gastroesophageal reflux disease: the presence of IL-1B-511*T/IL-1RN*1 (T1) haplotype may protect against the disease.
Chourasia D; Achyut BR; Tripathi S; Mittal B; Mittal RD; Ghoshal UC
Am J Gastroenterol; 2009 Nov; 104(11):2704-13. PubMed ID: 19603010
[TBL] [Abstract][Full Text] [Related]
10. Febrile seizures: interleukin 1beta and interleukin-1 receptor antagonist polymorphisms.
Serdaroğlu G; Alpman A; Tosun A; Pehlivan S; Ozkinay F; Tekgül H; Gökben S
Pediatr Neurol; 2009 Feb; 40(2):113-6. PubMed ID: 19135625
[TBL] [Abstract][Full Text] [Related]
11. Genetic variants of interleukin-1RN and interleukin-1beta genes and risk of cervical cancer.
Singh H; Sachan R; Goel H; Mittal B
BJOG; 2008 Apr; 115(5):633-8. PubMed ID: 18333945
[TBL] [Abstract][Full Text] [Related]
12. IL-1 gene polymorphisms and genetic susceptibility of gallbladder cancer in a north Indian population.
Vishnoi M; Pandey SN; Choudhuri G; Mittal B
Cancer Genet Cytogenet; 2008 Oct; 186(2):63-8. PubMed ID: 18940468
[TBL] [Abstract][Full Text] [Related]
13. Association of interleukin-1Ra gene polymorphism in patients with bladder cancer: case control study from North India.
Bid HK; Manchanda PK; Mittal RD
Urology; 2006 May; 67(5):1099-104. PubMed ID: 16698387
[TBL] [Abstract][Full Text] [Related]
14. Heat-shock protein gene polymorphisms and the risk of nephropathy in patients with Type 2 diabetes.
Buraczynska M; Swatowski A; Buraczynska K; Dragan M; Ksiazek A
Clin Sci (Lond); 2009 Jan; 116(1):81-6. PubMed ID: 18518860
[TBL] [Abstract][Full Text] [Related]
15. Genetic association of interleukin-1beta (-511C/T) and interleukin-1 receptor antagonist (86 bp repeat) polymorphisms with Type 2 diabetes mellitus in North Indians.
Achyut BR; Srivastava A; Bhattacharya S; Mittal B
Clin Chim Acta; 2007 Feb; 377(1-2):163-9. PubMed ID: 17069782
[TBL] [Abstract][Full Text] [Related]
16. Effect of MDR1 gene polymorphism on progression of end-stage renal disease.
Zhang WX; Chen B; Zhang W; Chen N; Yu ZC; Cai WM
Acta Pharmacol Sin; 2007 Apr; 28(4):579-83. PubMed ID: 17376299
[TBL] [Abstract][Full Text] [Related]
17. Endothelial nitric oxide synthase gene intron 4 polymorphism in patients with end-stage renal disease.
Buraczynska M; Ksiazek P; Zaluska W; Nowicka T; Ksiazek A
Nephrol Dial Transplant; 2004 Sep; 19(9):2302-6. PubMed ID: 15299097
[TBL] [Abstract][Full Text] [Related]
18. Complement factor H gene polymorphism and risk of cardiovascular disease in end-stage renal disease patients.
Buraczynska M; Ksiazek P; Zukowski P; Benedyk-Lorens E; Orlowska-Kowalik G
Clin Immunol; 2009 Aug; 132(2):285-90. PubMed ID: 19428307
[TBL] [Abstract][Full Text] [Related]
19. Genetic association of interleukin-1β (-511C/T) and its receptor antagonist (86-bpVNTR) gene polymorphism with susceptibility to bacteremia in kidney transplant recipients.
Wan QQ; Ye QF; Ma Y; Zhou JD
Transplant Proc; 2012 Dec; 44(10):3026-8. PubMed ID: 23195019
[TBL] [Abstract][Full Text] [Related]
20. Potential influence of interleukin-1 haplotype IL-1 beta-511*T-IL-1RN*1 in conferring low risk to middle third location of esophageal cancer: a case-control study.
Upadhyay R; Jain M; Kumar S; Ghoshal UC; Mittal B
Hum Immunol; 2008 Mar; 69(3):179-86. PubMed ID: 18396210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
